Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 21/3/2018
SIETES contiene 92210 citas

<< anterior 21 a 40 de 2368 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Chahal JS, Khan OF, Cooper CL, McPartlan JS, Tsosie JK, Tilley LD, Sidik SM, Lourido S, Langer R, Bavari S, Ploegh HL, Anderson DG. Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose. Proceedings of the National Academy of Sciences of the United States of America 2016;113:E4133-42. [Ref.ID 100595]
22. Cita con resumen
Anónimo. PhRMA boosts lobbying spending in Q2 of this year. DIA Daily 2016:1. [Ref.ID 100505]
24. Cita con resumen
Kuehn BM. FDA's foray into big data still maturing. JAMA 2016;315:1934-6. [Ref.ID 100291]
25. Cita con resumen
Moore TJ, Furberg CD. Electronic health data for postmarket surveillance: a vision not realized. Drug Saf 2015;38:601-10. [Ref.ID 99852]
26.Tiene citas relacionadas Cita con resumen
Sutter RW, Bahl S, Deshpande JM, Verma H, Ahmad M, Venugopal P, Rao JV, Agarkhedkar S, Lalwani SK, Kunwar A, Sethi R, Takane M, Mohanty L, Chatterjee A, John TJ, Jafari H, Aylward RB. Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention. an open-label, randomised controlled trial. Lancet 2015;386:2413-21. [Ref.ID 99767]
27.Tiene citas relacionadas Cita con resumen
Garon JR, Orenstein WA. A worldwide shift in polio vaccines for routine immunisation. Lancet 2015;386:2375-7. [Ref.ID 99752]
28. Cita con resumen
Kmietowicz Z. Pfizer and Allergan agree $160bn merger deal. BMJ 2015;351:h6342. [Ref.ID 99704]
29. Cita con resumen
Ludvigsson JF, Ström P, Lundholm C, Cnattingius S, Ekbom A, Órtqvist A, Feltelius N, Granath F, Stephansson O. Maternal vaccination against H1N1 influenza and offspring mortality: population based cohort study and sibling design. BMJ 2015;351:h5585. [Ref.ID 99695]
30. Cita con resumen
Day M. Italian expert questions need for expanded vaccination schedule. BMJ 2015;351:h6181. [Ref.ID 99693]
31. Cita con resumen
Anónimo. What next for the malaria RTS,S vaccine candidate?. Lancet 2015;386:1708. [Ref.ID 99666]
32. Cita con resumen
Maurice J. And then there were two…polio-endemic countries. Lancet 2015;386:1521-2. [Ref.ID 99659]
33. Cita con resumen
Anónimo. Influenza vaccine for 2015-2016. Med Lett Drugs Ther 2015;57:125-7. [Ref.ID 99652]
34.Tiene citas relacionadas Cita con resumen
Simmons CP. A candidate dengue vaccine walks a tightrope. N Engl J Med 2015;373:1263-4. [Ref.ID 99601]
35. Cita con resumen
Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT. Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiology, Biomarkers, & Prevention 2015;24:1673-9. [Ref.ID 99571]
36.Tiene citas relacionadas Cita con resumen
Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, Carroll MW, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Hossmann S, Kondé GN, Soumah A, Trelle S, Vicari AS, Watson CH, Kieny MP, Rottingen J-A. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 2015;386:857-66. [Ref.ID 99512]
37.Tiene citas relacionadas Cita con resumen
Anónimo. An ebola vaccine: first results and promising opportunities. Lancet 2015;386:830. [Ref.ID 99511]
38. Cita con resumen
Leung I, Harpaz R. Impact of the maturing varicella vaccination program on varicella and related outcomes in the United States: 1994–2012. Journal of the Pediatric Infectious Diseases Society 2015:12 de agosto. [Ref.ID 99388]
40.Tiene citas relacionadas
Moorthy VS, Okwo-Bele J-M. Final results from a pivotal phase 3 malaria vaccine trial. Lancet 2015;386:5-7. [Ref.ID 99327]
Seleccionar todas
<< anterior 21 a 40 de 2368 siguiente >>